Cancer
Gene-Engineered Neural Stem/Progenitor Cells Demonstrate Tumor-Selective Migration and Antitumor Effects in Glioma
Recent research from the United States has presented fresh data on cancer gene therapy, particularly in the treatment of glioblastoma multiforme (GBM). The study, led by J. Mercapide and colleagues from the University of South Alabama, Cancer Institute, investigated the use of primary neural stem/progenitor cells (NSPC) as a